Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 21:4:F1000 Faculty Rev-1482.
doi: 10.12688/f1000research.7063.1. eCollection 2015.

Recent advances in treatment for Benign Prostatic Hyperplasia

Affiliations
Review

Recent advances in treatment for Benign Prostatic Hyperplasia

Simon van Rij et al. F1000Res. .

Abstract

Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbidity. The future of BPH treatments is exciting, and a number of novel techniques are currently under clinical trial.

Keywords: HOLEP; Holmium laser enucleation of the prostate; aquablation; benign prostatic hyperplasia; mirabegron; personalised medicine; prostate obstruction.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare that they have no competing interests.

No competing interests were disclosed.

References

    1. Saigal CS, Joyce G: Economic costs of benign prostatic hyperplasia in the private sector. J Urol. 2005;173(4):1309–13. 10.1097/01.ju.0000152318.79184.6f - DOI - PubMed
    1. Parsons JK: Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Curr Bladder Dysfunct Rep. 2010;5(4):212–8. 10.1007/s11884-010-0067-2 - DOI - PMC - PubMed
    1. Abrams P, Cardozo L, Fall M, et al. : The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78. 10.1002/nau.10052 - DOI - PubMed
    1. Gratzke C, Bachmann A, Descazeaud A, et al. : EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol. 2015;67(6):1099–109. 10.1016/j.eururo.2014.12.038 - DOI - PubMed
    1. McVary KT, Roehrborn CG, Avins AL, et al. : Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803. 10.1016/j.juro.2011.01.074 - DOI - PubMed
    2. F1000 Recommendation

LinkOut - more resources